StonvexLoading…
StonvexStonvexStonvexCore line items from RCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $48.54M | $46.50M | $19.81M |
Operating Income | $-43.60M | $-38.65M | $-25.65M |
Net Income | $-46.24M | $-50.72M | $-32.39M |
EPS (Diluted) | $-1.03 | $-2.09 | $-1.69 |
Total Assets | $12.65M | $17.56M | $7.34M |
Total Liabilities | $19.62M | $86.33M | $29.91M |
Cash & Equivalents | $478.98K | $800.74K | $554.72K |
Free Cash Flow OCF − CapEx | $-37.13M | $-35.31M | $-22.14M |
Shares Outstanding | 55.32M | 25.00M | 21.67M |